bioRxivMolecular BiologyPreprint
Transcriptomic Suppression of Immune and Regenerative Signalling in Skeletal Muscle of Patients with Chronic Kidney Disease
Luke A. BakeriD, Nicholas C. EastleyiD, Robert U. AshfordiD, Matthew J. Denniff, Matthew P. M. Graham-BrowniD, Emma L WatsoniD
Abstract
BackgroundChronic kidney disease (CKD) is a growing public health emergency with a global prevalence of approximately 14%. Sarcopenia is a common complication of CKD contributing to functional decline and poor outcomes. However, the molecular mechanisms driving muscle wasting in CKD remain incompletely understood. This study aimed to characterise the transcriptomic profile in individuals with CKD compared to healthy control counterparts, to identify key pathways implicated in muscle dysfunction. MethodsVastus lateralis muscle biopsy samples were obtained from n=10 people with CKD and n=9 healthy controls matched for age, sex, ethnicity and physical activity. Bulk RNA sequencing was performed on all samples. Differential gene expression was assessed using DESeq2 and pathway enrichments analyses were conducted using Gene Ontology (GO) and KEGG databases. ResultsA total of 76 genes were differentially expressed in CKD muscle (FDR < 0.05, |log2FC| [≥] 1), with 62 downregulated and 14 upregulated. Transcriptomic analysis revealed suppression of immune-related pathways, including leukocyte chemotaxis and macrophage-associated signalling (e.g., CD163, CXCL14, MPEG1). GO and KEGG analyses further supported downregulation of immune surveillance and inflammatory pathways. Several genes implicated in muscle regeneration (e.g., MEGF10, PODN, SOX4) were also differentially expressed, suggesting impaired regenerative signalling. Classical markers of myogenesis and protein degradation were unchanged, indicating a blunted rather than overtly inflammatory or catabolic muscle environment. ConclusionsSkeletal muscle in CKD exhibits a distinct transcriptional profile marked by suppression of immune and regenerative processes. These findings refine our understanding of CKD-associated sarcopenia and may inform the development of targeted therapeutic strategies beyond conventional exercise-based interventions.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The response of the skeletal muscle transcriptome to exercise in chronic kidney disease
Luke A. Baker, Matthew P. M. Graham-Brown, … Emma L Watson·bioRxiv·Apr 25, 2025
- Decreased miRNA-148a-3p expression in skeletal muscle of patients with chronic kidney disease
KA Robinson, LA Baker, … EL Watson·bioRxiv·May 24, 2022
- Establishment and characterisation of primary skeletal muscle cell cultures from patients with advanced Chronic Kidney Disease
L. A. Baker, T. F. O'Sullivan, … E. L. Watson·bioRxiv·Nov 16, 2020
- ROCK1 activates mitochondrial fission leading to oxidative stress and muscle atrophy
- Anabolic and catabolic responses to different modes of exercise in patients with chronic kidney disease
Doug William Gould, Luke A. Baker, … Emma L Watson·BMC NephrologyPeer-reviewed·Mar 13, 2026
- The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia
W. W. Cheung, R. Zheng, … R. H. Mak·bioRxiv·Feb 5, 2021